decitabine,
Showing 476 - 493 of 493
Acute Myeloid Leukemia Trial in Rochester (Decitabine, Rapamycin)
Completed
- Acute Myeloid Leukemia
-
Rochester, New YorkUniversity of Rochester
Oct 8, 2012
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Houston (Decitabine)
Completed
- Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Aug 1, 2012
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Houston (Decitabine)
Terminated
- Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Leukemia, MDS Trial in Houston (biological, drug, procedure)
Completed
- Leukemia
- Myelodysplastic Syndromes
- Filgrastim
- +4 more
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Jul 27, 2012
Untreated Adult Acute Myeloid Leukemia, Effect of Drugs, Drug Safety Trial (Decitabine)
Unknown status
- Untreated Adult Acute Myeloid Leukemia
- +2 more
- (no location specified)
Jul 4, 2012
Renal Cell Carcinoma Trial in Houston (Decitabine, Interferon Alfa-2b)
Terminated
- Renal Cell Carcinoma
- Decitabine
- Interferon Alfa-2b
-
Houston, TexasUT MD Anderson Cancer Center
Nov 22, 2011
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in St. Louis (Decitabine)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
St. Louis, MissouriWashington University School of Medicine
Aug 3, 2011
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Houston (5-Azacytidine (5-aza), Valproic Acid, All-Trans Retinoic
Completed
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
- 5-Azacytidine (5-aza)
- +2 more
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Jun 12, 2012
Leukemia Trial in St. Louis (Decitabine (Dacogen))
Completed
- Leukemia
- Decitabine (Dacogen)
-
St. Louis, MissouriWashington University School of Medicine
Jul 2, 2011
Acute Myeloid Leukemia Trial in New York (decitabine)
Completed
- Acute Myeloid Leukemia
-
New York, New YorkWeill Medical College of Cornell University
Jun 29, 2011
Cancer Trial in Las Vegas (Decitabine and Pegylated Interferon-Alfa 2B)
Terminated
- Cancer
- Decitabine and Pegylated Interferon-Alfa 2B
-
Las Vegas, NevadaNevada Cancer Institute
Jul 19, 2011
Quality of Life of Acute Myelogenous Leukemia or Myelodysplastic
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Questionnaire
- Neurocognitive Testing
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 31, 2012
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in London (Decitabine)
Unknown status
- Acute Myeloid Leukemia
- +2 more
-
London, United KingdomKing's College Hospital NHS Foundation Trust
Sep 2, 2010
Acute Myelogenous Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Paris (5 azacytidine - VALPROIC acid- Retinoic acid)
Completed
- Acute Myelogenous Leukaemia (AML)
- Myelodysplastic Syndrome (MDS)
- 5 azacytidine - VALPROIC acid- Retinoic acid
-
Paris, FranceChu Saint Louis
May 6, 2011
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Oct 12, 2009
Acute Myeloid Leukemia Trial in Germany, Netherlands (Decitabine 15 mg/m2 i.v.)
Completed
- Acute Myeloid Leukemia
- Decitabine 15 mg/m2 i.v.
-
Hannover, Niedersachsen, Germany
- +7 more
Mar 19, 2009
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Dec 12, 2007